142 related articles for article (PubMed ID: 38685144)
21. Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study.
Ramsdale E; Malhotra A; Holmes HM; Zubkoff L; Wang J; Mohile S; Norton SA; Duberstein PR
Support Care Cancer; 2023 Oct; 31(12):636. PubMed ID: 37847423
[TBL] [Abstract][Full Text] [Related]
22. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel.
Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM
Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042
[TBL] [Abstract][Full Text] [Related]
23. Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.
Tangiisuran B; Rajendran V; Sha'aban A; Daud NAA; Nawi SNM
Int J Clin Pharm; 2022 Feb; 44(1):201-213. PubMed ID: 34642869
[TBL] [Abstract][Full Text] [Related]
24. Challenges in Deprescribing among Older Adults in Post-Acute Care Transitions to Home.
Wang J; Shen JY; Yu F; Nathan K; Caprio TV; Conwell Y; Moskow MS; Brasch JD; Simmons SF; Mixon AS; Norton SA
J Am Med Dir Assoc; 2024 Jan; 25(1):138-145.e6. PubMed ID: 37913819
[TBL] [Abstract][Full Text] [Related]
25. The role of pharmacists in deprescribing benzodiazepines: A scoping review.
Ashkanani FZ; Rathbone AP; Lindsey L
Explor Res Clin Soc Pharm; 2023 Dec; 12():100328. PubMed ID: 37743854
[TBL] [Abstract][Full Text] [Related]
26. Hospital pharmacists' and patients' views about what constitutes effective communication between pharmacists and patients.
Chevalier BAM; Watson BM; Barras MA; Cottrell WN
Int J Pharm Pract; 2018 Oct; 26(5):450-457. PubMed ID: 29210472
[TBL] [Abstract][Full Text] [Related]
27. Deprescribing as an Opportunity to Facilitate Patient-Centered Care: A Qualitative Study of General Practitioners and Pharmacists in Japan.
Ie K; Machino R; Albert SM; Tomita S; Kushibuchi M; Hirose M; Matsuda T; Okuse C; Ohira Y
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834238
[TBL] [Abstract][Full Text] [Related]
28. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
[TBL] [Abstract][Full Text] [Related]
29. Stakeholders' views and experiences of pharmacist prescribing: a systematic review.
Jebara T; Cunningham S; MacLure K; Awaisu A; Pallivalapila A; Stewart D
Br J Clin Pharmacol; 2018 Sep; 84(9):1883-1905. PubMed ID: 29873098
[TBL] [Abstract][Full Text] [Related]
30. What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.
Radcliffe E; Servin R; Cox N; Lim S; Tan QY; Howard C; Sheikh C; Rutter P; Latter S; Lown M; Brad L; Fraser SDS; Bradbury K; Roberts HC; Saucedo AR; Ibrahim K
BMC Geriatr; 2023 Sep; 23(1):591. PubMed ID: 37743469
[TBL] [Abstract][Full Text] [Related]
31. Influence of a general practice pharmacist on medication management for patients at risk of medicine-related harm: A qualitative evaluation.
Jordan M; Young-Whitford M; Mullan J; Stewart A; Chen TF
Aust J Gen Pract; 2022 Jul; 51(7):521-528. PubMed ID: 35773164
[TBL] [Abstract][Full Text] [Related]
32. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist.
Muijrers PE; Knottnerus JA; Sijbrandij J; Janknegt R; Grol RP
Pharm World Sci; 2003 Oct; 25(5):235-41. PubMed ID: 14584231
[TBL] [Abstract][Full Text] [Related]
33. Pharmacists' contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis.
Melo TAR; Bezerra CO; Fernandes BD; Rotta I; Reis WCT; Aguiar PM
Int J Clin Pharm; 2023 Oct; 45(5):1037-1049. PubMed ID: 37713028
[TBL] [Abstract][Full Text] [Related]
34. Community-based pharmacists' role in deprescribing: A systematic review.
Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
[TBL] [Abstract][Full Text] [Related]
35. Assessing care team perspectives on integration of a community pharmacist into an ambulatory care practice.
Riggins SR; Abode AM; Holland CR; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S122-S128.e1. PubMed ID: 31231003
[TBL] [Abstract][Full Text] [Related]
36. Student Perspectives on the Pharmacist's Role in Deprescribing Opioids: A Qualitative Study.
Cernasev A; Barenie RE; Metzmeier S; Axon DR; Springer SP; Scott D
Pharmacy (Basel); 2023 Jul; 11(4):. PubMed ID: 37489347
[TBL] [Abstract][Full Text] [Related]
37. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
Kua CH; Mak VS; Lee SWH
BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
[TBL] [Abstract][Full Text] [Related]
38. The experiences of healthcare providers who refer to a campus-based pharmacy clinic: a qualitative analysis.
Wheeler TF; Leitch S; Marra CA
J Prim Health Care; 2024 Jun; 16(2):190-197. PubMed ID: 38941248
[TBL] [Abstract][Full Text] [Related]
39. Negotiating "Unmeasurable Harm and Benefit": Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting.
Anderson K; Foster M; Freeman C; Luetsch K; Scott I
Qual Health Res; 2017 Nov; 27(13):1936-1947. PubMed ID: 29088989
[TBL] [Abstract][Full Text] [Related]
40. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project.
Pottie K; Haydt S; Farrell B; Kennie N; Sellors C; Martin C; Dolovich L;
Res Social Adm Pharm; 2009 Dec; 5(4):319-26. PubMed ID: 19962675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
